Xcout Intel
Fore Biotherapeutics competitors & alternatives
The 12 closest competitors and alternatives to Fore Biotherapeutics among biotech companies — ranked by similarity to what Fore Biotherapeutics actually does, not by market-cap band.
Subscribe to see Fore Biotherapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Fore Biotherapeutics
Fore Biotherapeutics is a virtual precision oncology company rooted in science and innovation, with expertise and talent across the USA. The company is focused on developing treatments, including its Plixorafenib Program.
Fore Biotherapeutics at a glance
Fore Biotherapeutics is a biotech company headquartered in United States. Its most recent funding round, Series D, raised $67M in July 2026. Xcout tracks 11 named people at Fore Biotherapeutics, including William Hinshaw (Chief Executive Officer and Member of the Board of Directors).
Fore Biotherapeutics leadership
- William HinshawChief Executive Officer and Member of the Board of Directors
- Michael ByrnesChief Financial Officer
- Stacie Peacock Shepherd, M.D., Ph.D.Chief Medical Officer
- Giovanni MariggiCo-founder and Partner at Medicxi
- Payman Darouian, PharmDSr VP, Corporate Development, Strategy and Commercial
- Rajeev DadooCOO and Managing Partner of SR One
5 more named people on record for Fore Biotherapeutics, with roles, board committees and tenure — see the full roster →
Fore Biotherapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $67M | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Fore Biotherapeutics news
Top 12 Fore Biotherapeutics competitors
Ranked by semantic similarity — how close each company is to Fore Biotherapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Similar biotech company
FoRx Therapeutics is a privately held clinical-stage biotechnology company headquartered in Basel, Switzerland. The company pioneers precision therapeutics targeting DNA Replication Stress in cancer treatment. Its office is located at Lichtstrasse 35, 4056 Basel, Switzerland.
Biotechnology
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Biotechnology
Apeiron Therapeutics is a clinical-stage biopharmaceutical and precision oncology company focused on developing biomarker-driven therapeutics for cancer.
Biotechnology
Alterome Therapeutics, Inc. is a clinical-stage precision oncology company headquartered in San Diego, California, founded in 2021. The privately held biotech firm focuses on developing targeted therapies to address genomically defined cancer drivers and intractable oncological targets.
Biotechnology
Edison Oncology Holding Corp is a clinical-stage biopharmaceutical company that develops first-in-class, small-molecule, biomarker-driven therapies to target major cancer markets. The company identifies, acquires, and advances underdeveloped drug candidates to address critical unmet needs for cancer patients with specific genetic mutations.
Biotechnology
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Biotechnology
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Biotechnology
Prelude Therapeutics, Inc. is a clinical-stage precision oncology company focused on identifying and developing innovative, targeted cancer treatments for patient populations with unmet medical needs. Its pipeline includes PRT543, currently undergoing Phase 1 clinical evaluation for certain solid tumors and myeloid malignancies. Another asset, PRT811, is also in Phase 1 trials, targeting various solid tumors, notably glioblastoma multiforme. The company is additionally progressing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a powerful and highly kinome-selective CDK9 inhibitor; PRT-SCA2, which is in preclinical development for several genomically selected cancers; PRT3645, a brain-penetrant molecule that precisely and effectively targets CDK4/6; and PRT-K4, another preclinical compound for solid tumors. Founded in 2016, the firm's headquarters are located in Wilmington, Delaware.
Biotechnology
Core Biomedicine is a preclinical-stage biotechnology and pharmaceutical manufacturing company pioneering lineage-based precision oncology therapeutics.
Similar biotech company
AUM Biosciences is a clinical-stage biotechnology company that develops precision oncology therapeutics utilizing multi-faceted inhibition strategies to overcome cancer drug resistance. The company serves patients and the healthcare sector by advancing a targeted clinical pipeline designed to combat tumor evasion and treatment resistance.
Similar biotech company
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Fore Biotherapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Fore Biotherapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →